Abstract
Pregnancy in a diabetic woman brings about many changes that can lead to the development of diabetic retinopathy (DR) or worsening of pre-existing disease. In some patients this may develop into sight threatening disease which, if not treated adequately, can cause devastating visual impairment. There is a lack of established guidelines for screening these patients during pregnancy. In this article we discuss the physiological changes during pregnancy that contribute to worsening of diabetic retinopathy and review the relative contribution of risk factors to the underlying pathological processes. It is important to identify and treat any pre-existing retinopathy in diabetic women considering pregnancy and optimise glycaemic control prior to conception. Rapid tightening of glycaemic control after conception is associated with a less favourable outcome. Based on the existing literature we suggest guidelines for diabetic retinopathy screening for women during pregnancy. Established sight-threatening retinopathy should be treated at an earlier stage in pregnant women compared to non-pregnant diabetics with a similar disease.
Keywords: Diabetic retinopathy, Diabetes mellitus, Pregnancy, Laser photocoagulation, Screening
Current Diabetes Reviews
Title: Diabetic Retinopathy in Pregnancy
Volume: 5 Issue: 3
Author(s): Ajay Bhatnagar, Abdul-Jabbar Ghauri, Monique Hope-Ross and Peck L. Lip
Affiliation:
Keywords: Diabetic retinopathy, Diabetes mellitus, Pregnancy, Laser photocoagulation, Screening
Abstract: Pregnancy in a diabetic woman brings about many changes that can lead to the development of diabetic retinopathy (DR) or worsening of pre-existing disease. In some patients this may develop into sight threatening disease which, if not treated adequately, can cause devastating visual impairment. There is a lack of established guidelines for screening these patients during pregnancy. In this article we discuss the physiological changes during pregnancy that contribute to worsening of diabetic retinopathy and review the relative contribution of risk factors to the underlying pathological processes. It is important to identify and treat any pre-existing retinopathy in diabetic women considering pregnancy and optimise glycaemic control prior to conception. Rapid tightening of glycaemic control after conception is associated with a less favourable outcome. Based on the existing literature we suggest guidelines for diabetic retinopathy screening for women during pregnancy. Established sight-threatening retinopathy should be treated at an earlier stage in pregnant women compared to non-pregnant diabetics with a similar disease.
Export Options
About this article
Cite this article as:
Bhatnagar Ajay, Ghauri Abdul-Jabbar, Hope-Ross Monique and Lip L. Peck, Diabetic Retinopathy in Pregnancy, Current Diabetes Reviews 2009; 5 (3) . https://dx.doi.org/10.2174/157339909788920929
DOI https://dx.doi.org/10.2174/157339909788920929 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Environmental Factors and Hypertension
Current Pharmaceutical Design COVID-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods
Anti-Cancer Agents in Medicinal Chemistry Chronic Exposure to Low-Level Cadmium in Diabetes: Role of Oxidative Stress and Comparison with Polychlorinated Biphenyls
Current Drug Targets Medico-Legal Evaluation of Fatal Perinatal Asphyxia
Current Pediatric Reviews Efficacy of Topical Formulations in Healing of Caesarean Scars Using Non-Invasive Devices: A Controlled Trial
Applied Drug Research, Clinical Trials and Regulatory Affairs Editorial [Hot topic: Transportalopathy and Vascular Cell Dysfunction (Guest Editor: Luis Sobrevia)]
Current Vascular Pharmacology Structural Chromosome Abnormalities Associated with Obesity: Report of Four New Subjects and Review of Literature
Current Genomics Realising Heart Regeneration
Current Tissue Engineering (Discontinued) Nitrogen Biobank for Cardiovascular Research
Current Cardiology Reviews Single Blastocyst Transfer: Contemporary Experience
Current Women`s Health Reviews Editorial (Thematic Issue: “Pregnancy in Women with Metabolic Syndrome”)
Current Pharmaceutical Biotechnology Vascular Endothelial Growth Factor in Central Nervous System Injuries – A Vascular Growth Factor Getting Nervous?
Current Neurovascular Research A Review of the Cardiovascular and Anti-Atherogenic Effects of Ghrelin
Current Pharmaceutical Design Germinal and Somatic Trisomy 21 Mosaicism: How Common is it, What are the Implications for Individual Carriers and How Does it Come About?
Current Genomics Obesity and Pregnancy
Current Women`s Health Reviews FGF10 and FGF21 as Regulators in Adipocyte Development and Metabolism
Endocrine, Metabolic & Immune Disorders - Drug Targets Metabolic Syndrome X is a Low-Grade Systemic Inflammatory Condition with its Origins in the Perinatal Period
Current Nutrition & Food Science New Horizons in Diabetes Therapy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Molecular Basis of Obesity: Current Status and Future Prospects
Current Genomics Biology of Protooncogene c-kit Receptor and Spermatogenesis
Current Pharmacogenomics